Literature DB >> 10554127

Age at time of hepatitis Be antibody seroconversion in childhood chronic hepatitis B infection and mutant viral strain detection rates.

T Ando1, K Sugiyama, K Goto, Y Miyake, R Li, Y Kawabe, Y Wada.   

Abstract

BACKGROUND: Investigations of adult patients have demonstrated that with seroconversion, changes occur from wild-type strains of the infecting virus to mutant strains. However, to date, there have been few reports and insufficient investigation of this issue in children.
METHODS: The presence or absence of nucleotide base and amino acid sequence mutations in a portion of the X region containing the core promoter region, the pre-C region, and the C region of HBV genomic DNA were investigated using a polymerase chain reaction-direct sequencing method on serum samples collected from 14 children who were hepatitis Be antibody (HBeAb)-positive carriers. Samples from three children who were HBe antigen (HBeAg)-positive carriers served as the control subjects.
RESULTS: When patients were grouped based on whether they had had documented seroconversion before age 6 or at age 6 or older, differences in mutant viral detection rates involving the core promoter region and the pre-C region were apparent. Specifically, a mutant strain showing a G-to-A substitution at nucleotide 83 in the pre-C region, or a mutant strain showing an A-to-T substitution at nucleotide 1762 and a G-to-A substitution at nucleotide 1764, was detected in only two of eight cases (25%) from the HBeAb-positive carriers with documented seroconversion before age 6. In contrast, these findings were present in six of six patients (100%) with documented seroconversion at age 6 or older.
CONCLUSIONS: The results of the present study suggest that the mechanism of onset of HBeAb seroconversion differs between children aged less than 6 years and those who are aged 6 or more.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10554127     DOI: 10.1097/00005176-199911000-00020

Source DB:  PubMed          Journal:  J Pediatr Gastroenterol Nutr        ISSN: 0277-2116            Impact factor:   2.839


  2 in total

Review 1.  New perspective on the natural course of chronic HBV infection.

Authors:  Yong-Yuan Zhang; Ke-Qin Hu; Zhongping Duan
Journal:  Front Med       Date:  2014-05-29       Impact factor: 4.592

2.  Safety, immunization coverage and determinants of a new kind of Hepatitis B vaccine firstly applied in Ningbo, China.

Authors:  Sijia Yang; Xiao Ma; Hongxia Ni; Shaoying Zhou; Danbiao Hu; Honghui Shi; Xiaoying Chen; Hongjun Dong; Guozhang Xu
Journal:  Hum Vaccin Immunother       Date:  2015-07-25       Impact factor: 3.452

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.